|
|
|
|
European Biopharmaceutical Review |
| |
|
European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.
With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.
Connect with us on Twitter: follow @EBRmagazine
Read
our publications on the go in the Samedan app for iPhone and iPad. You
can download issues for offline reading and our archives go as far back
as 2008! Download for free on the App Store. 
|
|
|
|
|
|
 02.02.15.jpg)
 |
Industry Events |
 |
DIA Annual Clinical Forum
14-15 April 2015, Paris, France
The 27th DIA
Clinical Forum 2015, held in Paris from 14 – 15 April offers the ideal venue
for professionals seeking to understand the professional implications of the
changing European research environment.
More info >> |
|
 |
News and Press Releases |
 |
Europital participates at the next Clinical Trials Innovation Programme 2015
Gent, Belgium: February 10th, 2015 – Europital will attend the upcoming
Clinical Trials Innovation Programme (CTIP) 2015 that takes place next
3rd and 4th of March in the cosmopolitan city of Munich.
More info >> |
|
 |
White Papers |
 |
|
Running Better Trials Taking an Intelligent Monitoring Approach
Bioclinica
When it comes to implementing a risk-based monitoring program, it is not
just about reducing monitoring visits and doing less Source Document
Verification (SDV). It’s about bringing together your people, a solid
process, and the right technology to run a better trial.
Success
with risk-based monitoring requires the ability to make sense of the
thousands, if not millions, of data points captured by multiple
disparate sources in a clinical trial. With the sheer volume of data
generated on a daily basis comes complexity. How does one make sense of
it all? Information overload burdens even the most experienced study
teams who struggle to understand which data matters most and what it
means.
More info >> |
|
|
